Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molidustat PK/PD in Renal Impairment
NCT02312973Phase 1Completed
- Sponsor
- Bayer
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of molidustat in anemia of chronic kidney disease (CKD-A) (3 arms), sponsored by Bayer. Primary endpoints: Maximum Plasma Concentration of Molidustat, Area Under the Curve of Molidustat and 2 more. Started Jan 2015; status: completed.
02
Drugs
molidustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02312973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312973.